DNA Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 May 2024 @ 16:00):

Stats
Today's Volume	54.42M
Average Volume	29.71M
Market Cap	2.10B
EPS	$0 ( 2024-02-29 )
Next earnings date	( $-0.0800 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.08
ATR14	$0.00300 (0.31%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-25	Canton Barry	Buy	5 000 000	Stock Option
2024-04-25	Shetty Reshma P.	Buy	5 000 000	Stock Option
2024-04-25	Kelly Jason R	Buy	5 000 000	Stock Option
2024-04-01	Dmytruk Mark E.	Sell	22 916	Restricted Stock Units
2024-04-01	Dmytruk Mark E.	Buy	1 634	Class A Common Stock

INSIDER POWER
66.44
Last 100 transactions
Buy: 17 333 675 \| Sell: 4 208 500

Volume Correlation

Long: 0.48 (neutral)

Short: 0.85 (strong)

Signal:(61.542) Same movement expected

Ginkgo Bioworks Holdings, Correlation

10 Most Positive Correlations
ATTO	0.927
KT	0.92
DHX	0.918
ARMK	0.912
WF	0.911
PDS	0.911
WRBY	0.902
MYTE	0.902
AVYA	0.899
AMRC	0.899

10 Most Negative Correlations
RXN	-0.884
MOG-B	-0.881
DSE	-0.872
COR	-0.872
MSP	-0.87
PSXP	-0.868
AMAM	-0.864
TNK	-0.855
CMO	-0.851
FPAC	-0.851

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Ginkgo Bioworks Holdings, Correlation - Currency/Commodity

0.56
( weak )

0.66
( moderate )

0.00
( neutral )

-0.67
( moderate negative )

-0.64
( weak negative )

Ginkgo Bioworks Holdings, Financials

Annual	2023
Revenue:	$251.46M
Gross Profit:	$142.64M (56.73 %)
EPS:	$-0.460

FY	2023
Revenue:	$251.46M
Gross Profit:	$142.64M (56.73 %)
EPS:	$-0.460

FY	2022
Revenue:	$477.71M
Gross Profit:	$273.49M (57.25 %)
EPS:	$-1.250

FY	2021
Revenue:	$313.84M
Gross Profit:	$204.16M (65.05 %)
EPS:	$-1.231

Financial Reports:

No articles found.

Ginkgo Bioworks Holdings,

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Realtime updates for Ginkgo Bioworks Holdings, [DNA]

Upcoming Earnings Alert